---
title: "Docebo Buy Rating Reaffirmed as Strategic Investments and Strong Growth Outlook Support Unchanged $31 Price Target"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293057774.md"
description: "Needham analyst Ryan MacDonald reaffirmed a Buy rating on Docebo with an unchanged $31 price target. The recommendation is supported by strong growth outlooks, including raised full-year 2026 revenue guidance and preliminary Q2 revenue beating expectations. MacDonald views the company's substantial share repurchase as shareholder-friendly and strategic R&D spending as beneficial for future innovation, despite near-term profitability pressures."
datetime: "2026-07-17T15:55:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293057774.md)
  - [en](https://longbridge.com/en/news/293057774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293057774.md)
---

# Docebo Buy Rating Reaffirmed as Strategic Investments and Strong Growth Outlook Support Unchanged $31 Price Target

Analyst Ryan MacDonald of Needham reiterated a Buy rating on Docebo, retaining the price target of $31.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Ryan MacDonald has given his Buy rating due to a combination of factors tied to capital allocation, growth, and valuation. He views the substantial issuer bid, funded through cash and an expanded credit facility, as a shareholder-friendly move that signals confidence in Docebo’s intrinsic value. The repurchase at a defined premium price supports the stock and reflects management’s belief that current trading levels undervalue the business.

Moreover, he highlights that preliminary second-quarter revenue exceeded market expectations and that full‑year 2026 revenue guidance was raised, underscoring durable demand for Docebo’s platform. While near‑term profitability is tempered by heavier R&D spending, he interprets this as a strategic investment to accelerate product innovation ahead of a broader learning‑management refresh cycle, with key third‑party headwinds expected to ease in 2027. Together with an unchanged $31 price target, these dynamics underpin his positive risk‑reward view and support the Buy recommendation.

MacDonald covers the Technology sector, focusing on stocks such as Docebo, Duolingo, and Nerdy. According to TipRanks, MacDonald has an average return of \-9.7% and a 37.62% success rate on recommended stocks.

### Related Stocks

- [DCBO.US](https://longbridge.com/en/quote/DCBO.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [DUOL.US](https://longbridge.com/en/quote/DUOL.US.md)
- [NRDY.US](https://longbridge.com/en/quote/NRDY.US.md)

## Related News & Research

- [Docebo (DCBO) Expected to Announce Quarterly Earnings on Friday](https://longbridge.com/en/news/294458270.md)
- [3 AI Stocks Screening Cheap In Enterprise Software](https://longbridge.com/en/news/294024437.md)
- [United States Brent Oil Fund LP ETF announces June NAV of $40.41](https://longbridge.com/en/news/294302677.md)
- [AI Stocks With Real Enterprise Software Exposure Investors Should Watch](https://longbridge.com/en/news/293875371.md)
- [Capgemini: Solid Top-Line Momentum but Margin Concerns Keep Near-Term Upside Limited; Hold Rating Reiterated with Unchanged $95 Price Target](https://longbridge.com/en/news/294314103.md)